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Implications for Rehabilitation
 Care for people with MND demands a flexible approach to accommodate the diversity of 
clinical needs and relentless physical deterioration
 Telehealth allows clinicians to provide person-centred care for everyone with MND through 
frequent monitoring
 Holistic and rehabilitative service facilitated by telehealth is generally acceptable and 
preferred to routine appointments among MND NIV patients
 Telehealth promotes time efficient engagement with professionals that leads to symptom 
awareness and interpretation, while benefiting physical and psychological well-being of 
MND NIV patients
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1 Experience of Telehealth in People with Motor Neurone Disease using Non-
2 Invasive Ventilation  
3 Abstract
4 Introduction: Evidence is emerging that telehealth provides timely and cost-effective support for 
5 individuals with motor neurone disease (MND). However, little is known about the subjective 
6 experience of using telehealth. This study was designed to examine the experiences of using 
7 telemonitoring in patients with MND on non-invasive ventilation (NIV). 
8 Methods: Semi-structured interviews were conducted with seven patients (five males; mean 
9 age=63yrs; median illness duration=14m), who used a telemonitoring device for 24 weeks. 
10 Caregivers were present at five of the interviews; they supported communications and provided 
11 their feedback. Interviews were audio recorded and transcribed verbatim. Thematic analysis was 
12 conducted to find overarching themes. 
13 Results:  Five themes were identified: Benefits of Timely Intervention, Reducing the Unnecessary, 
14 Increased Self-Awareness, Taking Initiative, and Technical Challenges. Overall, timely interventions 
15 were observed as a result of regular monitoring, contributing to both physical and psychological 
16 well-being of the participants. The patient-caregiver dyads suggested that telemonitoring could 
17 reduce costs, save time and ameliorate hassles associated with attending hospital appointments. 
18 Participants articulated that telemonitoring enabled symptom awareness and interpretation; the 
19 device also enabled the participants to raise concerns and/or requests to the healthcare 
20 professionals via the messaging system. Participants confirmed that the telemonitoring device was 
21 easy to use, despite some technical issues.
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22 Conclusions: Telemonitoring was positively experienced. The findings suggest this approach is 
23 empowering and effective in promoting patients’ well-being, while potentially reducing unnecessary 
24 clinical contact. 
25 Keywords: Telemonitoring; Telehealth; Qualitative study; Non-invasive ventilation; Motor neurone 
26 disease; Amyotrophic lateral sclerosis
27 Introduction
28 The United Kingdom National Institute for Health and Care Excellence (NICE) [1] recommends 
29 flexible approaches to the care of patients with motor neurone disease (MND) – also known as 
30 amyotrophic lateral sclerosis (ALS) – according to their needs. MND is a fatal neurodegenerative 
31 disease which primarily impacts on the motor systems. Appropriate symptom management, 
32 particularly of respiratory challenges, is refl cted in longer survival rates [2]. To this end, and to 
33 improve quality of life for patients, the NICE guidelines prompt clinicians to consider: an individual’s 
34 capability to attend the clinic, the appropriate frequency for their assessments and arrangements for 
35 prompt review when significant deterioration is declared. These recommendations reflect the 
36 diversity in symptomatology and prognosis [3], the relentless deterioration, and rapid progression of 
37 the condition towards the final stage [4]. The guideline also suggests the need for a new approach to 
38 meet the challenging task of accommodating the diversity of clinical needs. 
39 In view of the NICE guidelines, and the use of telehealth emerging as a promising platform for 
40 clinicians to provide flexible approaches, we developed a telemonitoring system, using the DocoboLtd 
41 Careportal® device. The device allows clinicians to monitor their service users more frequently, 
42 outside of the clinic, regarding their symptom changes, non-invasive ventilation (NIV) related issues, 
43 nocturnal blood oxygen saturation levels, and patient-ventilator interaction data. Careportal® also 
44 incorporates a messaging system for patient-clinician communications. The details of system and 
45 intervention protocol are reported elsewhere [5]. 
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46 There are a few studies that have examined telehealth systems in the care of MND. These include 
47 videoconferencing [6], nurse-led weekly telephone call follow-up [7,8], and weekly telemonitoring of 
48 NIV compliance [9,10]. Findings suggest that these telehealth systems are effective and provide an 
49 approach for meeting the NICE recommendations to tailor care for each patient. Nevertheless, the 
50 subjective experience of using telehealth must be explored to ensure that any changes to MND care 
51 procedures are not made at the expense of patients. Little is known of the advantages and 
52 disadvantages of telehealth for MND patients themselves. As far as we are aware, the only available 
53 report of subjective accounts of using a telehealth service amongst people with MND is based on a 
54 satisfaction questionnaire conducted via telephone [7]. There has been an attempt [11] to co-design 
55 a MND telehealth service with MND patients and carers; however, at the consultation meetings 
56 potential users of telehealth could only relate to aspirational benefits because at that time, none of 
57 the MND patients or their carers had used Telehealth.  
58 Amongst other illness groups (e.g. diabetes and chronic heart failure), there are suggestions that 
59 telemonitoring is supportive [12-19]. Patients generally found few problems using telemonitoring, 
60 and whilst some difficulties were reported – with either the telemonitoring technology or internet 
61 connectivity – these were minor [13,15,17]. Reports referred to a sense of reassurance and peace of 
62 mind through using telemonitoring system, which were attributed to perceived continuous 
63 monitoring and support by professionals [12,13, 18]. Also, telemonitoring has been linked with 
64 increased knowledge of one’s condition [12,18,19] and thereby facilitating patients to identify the 
65 ‘norm’ of their symptoms [12,19]. Although an increased awareness of symptoms may have a 
66 negative effect on the minority of patients [14,18], self-awareness of health status through 
67 telemonitoring was generally perceived to be positive and empowering to patients [12]. Hanley et al. 
68 further reported that telehealth promoted healthy behaviour, although they acknowledged that this 
69 may have been facilitated by participants’ awareness of their data was being monitored [15]. 
70 Telemonitoring was seen to be a more convenient approach for patients, and the need for less 
71 appointments with healthcare professionals was appreciated [15,18]. 
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72 Despite these positive findings of using a telehealth system, we cannot assuming subjective accounts 
73 of the benefits of telemonitoring in other chronic conditions will generalise to the MND population; 
74 there are clear differences in symptoms and prognoses of other conditions compared to MND. Thus, 
75 the current study was designed to explore subjective experiences of telehealth as facilitated by the 
76 Careportal® device as a regular monitoring service amongst people with MND who were using NIV.
77 Methods
78 Ethics
79 Ethical approval to conduct this study was obtained from United Kingdom National Health Service 
80 (NHS) Research Ethics Service (Ref no. anonymous) and the Research and Development department 
81 of the study site. 
82 Potential participants were given an information sheet about the study and written consent was 
83 obtained after participants had a chance to ask questions about the study and their role in it. 
84 Participants
85 Opportunity sampling was employed to recruit patients who had completed a 24-week trial of 
86 telemonitoring using Careportal® [5]. 13 patients with MND on NIV were recruited for the 24-week 
87 trial. Of the original 13, three patients died before the completion of the trial and an additional three 
88 before interviews were conducted. The remaining seven patients agreed to be interviewed about 
89 their experience of care associated with telemonitoring. Table 1 shows demographics and illness 
90 characteristics of the seven patients at the time of the trial. The median illness duration was 14 
91 months and the median time on NIV was 12 months. The average time between the end of trial and 
92 interview was 8 months. 
93 Five carers were also recruited to explore their experiences of using the Careportal®. An interview 
94 with the other two carers was perceived unnecessary by the patients because they had little 
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95 involvement during the trial. Joint interviews were preferred by patients and their carers thus an 
96 arrangement was made to interview them together. 
97 [Table 1 about here]
98 Data Collection
99 Semi-structured interviews were conducted by a non-clinical researcher, who monitored the weekly 
100 data input during the 24-week trial. Interview questions (Appendix 1) were developed by the 
101 research team to explore subjective experiences of using Careportal® and to understand the impact, 
102 if any, of having a telemonitoring service in the management of their MND illness situation. All 
103 questions were addressed to both patients and their carers with one extra question only applicable 
104 to the carers. 
105  All the interviews were conducted in participant’s homes. During the interview, John and Margaret 
106 used a communication device (i.e. iPad and an eye control computer), and three patients (i.e. John, 
107 Margaret, Mary) required communication support from their carer. Carer’s interpretations of 
108 patient’s comments were always checked with the patient. The length of interviews ranged between 
109 30 minutes and 50 minutes with an average duration of 35 minutes. Interviews were audio recorded 
110 and later transcribed verbatim. 
111 Data analysis
112 A qualitative study is explorative and researchers aim to understand subjective experiences of a 
113 particular phenomenon by immersing themselves in the data and – through an iterative analysis 
114 process – make sense of the narratives. As argued by Chamberlain, qualitative studies are interested 
115 in what underlies the surface to answer ‘how’ and ‘why’ questions [22]. Thematic analysis [23] was 
116 employed to answer ‘how’ telemonitoring service was perceived by the participants and ‘why’ it was 
117 so. Codes were inductively generated from the transcripts and they were later examined to identify 
118 the overarching themes, which were subsequently assessed to ensure that they reflected the data 
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119 set. Initial coding of the transcripts was assisted by software for qualitative analysis (NVivo11).  The 
120 analysis was conducted by the same non-clinical researcher who interviewed the participants. The 
121 credibility of the analysis was examined by the research team; the findings were presented at a team 
122 meeting, and a list of codes (Appendix 2) and all transcripts were shared with the team for a 
123 credibility examination. 
124 Results
125 Thematic analysis identified five themes: benefits of timely intervention, reducing the unnecessary, 
126 increased self-awareness, taking initiative, and technical challenges. The following section expands 
127 each theme using supportive quotes from the narrative accounts listed in brief sequential tables 2-6. 
128 Each quote is cross referenced from the table into narrative of interpretation. Three full stops in 
129 brackets indicate an omission of words. 
130 Benefits of timely intervention
131 Timely interventions were observed by six of the seven patients and all caregivers as a result of 
132 regular monitoring of clinical information via Careportal®, contributing to both physical and 
133 psychological well-being. Its benefits on physical well-being were observed when oximetry results 
134 prompted interventions (1)a. Whilst participants James and Charlie did not perceive any gain from 
135 Careportal® in terms of physical well-being at the time of trial, they still acknowledged potential 
136 benefits for the future (1)b. 
137 In addition to clinical benefits from using telemonitoring, a positive impact on psychological well-
138 being was reported. Participants appreciated their data being monitored by professionals who 
139 would make timely actions if they saw any irregular signs: (1)c. The significance of these positive 
140 impacts of Careportal® on psychological well-being was further highlighted by two participants who 
141 had identified psychological well-being to be the key to coping with the condition (1)d. 
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142 Whilst the benefits of timely intervention were expressed as above, John and his professional home 
143 carer did not perceive any benefits because of the good home care support he was receiving, as 
144 argued by his carer (1)e. Because of multiple daily visits from carers John similarly agreed that there 
145 were no benefits of telemonitoring for him, however he suggested 99% of people were likely to 
146 benefit: (1)f.
147 [Table 2 about here]
148 Reducing the Unnecessary
149 Given the accessibility of timely intervention via telemonitoring, participants were keen to utilise the 
150 device to reduce the current hospital appointments unless it was necessary. Five patients suggested 
151 Careportal® follow-ups to be more cost and time effective, besides reducing the hassles of attending 
152 the clinic – often described as brief with little benefit. In particular, James and Charlie, did not 
153 perceive any need for them to attend the clinics when little change in their physical well-being over 
154 time (2)a,b. Similarly, potential positive impact on health economics was noted by two participants. 
155 (2)c. 
156 For those more physically impaired by the condition, reduced hospital appointments were perceived 
157 to be beneficial as these were stressful experiences. Similar to time/cost effectiveness, these views 
158 were in the context of perceiving little benefit of face-to-face consultations. (2)d. Face-to-face 
159 consultation, however, was not completely dismissed. Mary and Logan were keen to regularly 
160 attend hospital because of the perceived advantage of direct contact with a consultant. (2)e. 
161 Nevertheless, the benefits may depend on the usefulness of hospital clinics considering Mary also 
162 suggested reducing appointments elsewhere in her interview. 
163 [Table 3 about here]
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164 Increased self-awareness
165 Participants were supportive of the regular monitoring of symptoms required by telemonitoring. 
166 Patients reported that this was a feature of having MND – appreciating that there are symptoms to 
167 experience and cope with. Their acceptance of telemonitoring then appeared to be a consequence 
168 of patients’ general understanding of fluctuations in their physical well-being (3)a. 
169 Telemonitoring further enabled symptom awareness and interpretation for four patients. For one 
170 patient, this was through voluntarily taking extra readings of pulse oximetry: (3)b. For Logan, it was 
171 through answering symptom related questions (3)c. Yet for another patient, having a follow-up 
172 conversation with the physiotherapist increased the symptom awareness. Furthermore, it was 
173 pointed out by two relatives that regularly monitoring symptoms led patients to be less biased and 
174 to become objective about their condition: (3)d
175 As illustrated above, being accurate about their symptoms and coming to understand more about 
176 their physical well-being as a part of the process of reporting through the Careportal® was perceived 
177 to be beneficial, and this was also voiced by Mary herself and Charlie. These accounts and the 
178 following quote suggest that telemonitoring can promote an active engagement with self-care (3)e.
179  [Table 4 about here]
180 Taking Initiative
181 Five of the seven patients were positive about their experiences from using the message system on 
182 the Careportal® because it allowed them to get in touch with the healthcare providers when they 
183 needed support (4)a. As illustrated, patients were able to register their concerns as the need arose, 
184 with the assurance of future contact from the healthcare providers. And, even though the answers 
185 may not be instant, this gave the patient ‘peace of mind’. The concerns that led to engaging with the 
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186 professionals were in relation to symptoms, general information, and equipment needs. This service 
187 format based around their needs was a sharp contrast to current communication with hospitals 
188 which was described as a one-way communication or communications with a long wait at best: (4)b.
189 Although the benefit of having the contact point was observed, this was not shared by William or 
190 John. Whilst William perceived the potential benefits, he had problems with sending messages (as 
191 shown below) therefore he never used the Careportal® to initiate contact. John did not perceive the 
192 benefits of having Careportal® as a contact point because he already had a good contact system set 
193 up as suggested by his carer: (4)c.  
194 [Table 5 about here]
195 Technical challenges
196 Although participants expressed general ease of using the telehealth device, a few technical issues 
197 were reported. Whilst most challenges were perceived as minor, or they were quickly solved by the 
198 Careportal® provider, four participants expressed frustration with the messaging system – in 
199 particular on-screen keyboard. This was used to draft messages to their health providers. 
200 Participants said the keys were too small, as well as the touch panel having insufficient sensitivity 
201 and the time allowance for formulating a message was also insufficient. In particular, the on-screen 
202 keyboard issues discouraged William from using the message system: (5)a. 
203 Other challenges were oximetry transmission (n=4), device fault (n=2), and mobile signal loss (n=1).
204 [Table 6 about here]
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205 Discussion
206 Interviews with seven MND patients who had used a weekly telemonitoring service via Careportal® 
207 strongly suggest that they accepted telehealth as a suitable support for them, and that it may 
208 provide new benefits to MND healthcare provision. Regular assessments of physical well-being via 
209 Careportal® were considered not only beneficial to symptom management, but also to psychological 
210 well-being because of the perceived continuity of support by medical staff. Using telehealth to 
211 potentially reduce unnecessary cost, time and hassles of attending hospital appointments were 
212 identified as an important benefit. The telehealth approach led participants to better understand 
213 their condition and enabled them to actively seek support for their needs. 
214 An investigation into the usefulness of telehealth in the care of people with MND has been slow 
215 compared to its development in other illnesses. To our knowledge, this was the first qualitative 
216 study to explore the experience of using remote monitoring for ventilated people with MND. The 
217 current study explored ‘why’ participants in the nurse-led telephone follow-up may have been 
218 satisfied with telehealth [7]. The findings of our study reflect the positive evaluations of people with 
219 other chronic conditions such as diabetes and chronic heart failure reported in previous qualitative 
220 works examining the subjective experience of telemonitoring. In line with these studies 
221 [12,13,18,19,24], patients suggested that monitoring their symptoms increased their knowledge of 
222 their symptoms – and this helped some individuals to establish their ‘norm’ [12,19]. In addition, as 
223 increased knowledge of one’s own health status has been found to encourage some patients to 
224 engage with behavioural health management including treatment adjustment [12,15,24], we 
225 similarly found proactive symptom management. In our study, the utilisation of the Careportal® 
226 device increased self-awareness of well-being amongst participants which promoted an active 
227 engagement with self-care. The positive impact of telemonitoring on psychological well-being 
228 observed in the present study has been also supported by previous studies, reporting telemonitoring 
229 gives patients a sense of reassurance [12,13,16,18,25]. Due to positive experiences and also benefits 
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230 of regular monitoring leading to timely interventions, our participants preferred telemonitoring to 
231 hospital appointments if they perceived hospital visits to create more burdens than benefits. This 
232 favourable response to a possible reduction of clinic appointment echoes the patients’ acceptability 
233 of telehealth in the care of MND by a recent study, which reported on the development of a 
234 telehealth system [11]. Similar to previous report [12,14,16,17,19], technical challenges of 
235 telemonitoring were generally perceived as a hassle, but did not detract from the benefits. 
236 The current study also provides a novel account of an individual for whom there was no perceived 
237 benefit of telemonitoring. Previously, an ambivalent attitude towards the benefits of telemonitoring 
238 was expressed mainly by professional carers [26], and therefore this study adds to the current 
239 understanding on potential patients to whom telehealth may provide little benefit. One study 
240 reports professionals’ view that telemonitoring is more beneficial for those with advanced condition 
241 with chronic heart failure than for those with stable symptoms [13]. In MND, initiation of NIV seems 
242 to be a good indication for introducing telemonitoring given the main cause of death is pulmonary 
243 complications [27,28]. Interestingly the current work notes that telemonitoring may not be 
244 perceived necessary for those with frequent daily visits from professional caregivers; though it 
245 should be noted the patient may not grasp the value of the technical data monitored and how that 
246 might be used to optimise care delivery such as ventilator settings.  
247 Limitations of the current study
248 No interview was conducted with patients who had declined to be part of the Telehealth trial that 
249 preceded this research [5]. Given that one of the factors affecting the uptake of telehealth is 
250 people’s motivation [29], perspectives of such individuals would be useful to scope if telehealth was 
251 to be translated into a formal service approach. Also, we have not sought interviews with the 
252 healthcare providers to explore their experiences of utilising the telemonitoring to provide care for 
253 ventilated patients with MND. Previous studies on telehealth in MND reported time and cost 
254 effectiveness of telehealth [7-10], yet studies in other chronic conditions found difficulties of 
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255 information sharing amongst professionals [13,14,23,26,30] which was potentially time consuming. 
256 Given the importance of multidisciplinary teams in delivering care in MND, the aspect of 
257 communication difficulties, and other potential problems, of using telehealth amongst the 
258 professionals needs to be defined. Although we attempted to capture the experience of lay carers in 
259 our study, only joint interviews were conducted at the request of both patients and caregivers. 
260 Nevertheless, it is reflected that carers of people with MND experience great burdens due to the 
261 illness [31], and thus a separate interview may have provided an environment for open discussion. 
262 Further examinations of carers’ experience of using telehealth in the care of MND NIV patients 
263 would be crucial especially in situations where patients become completely dependent on carers.     
264 Conclusions
265 The findings of this study suggest that telemonitoring via Careportal® may facilitate delivery of NICE 
266 recommendations relating to the care for p ople with MND. It is anticipated that this would extend 
267 to similar systems with appropriate procedures. In particular, amongst the non-invasively ventilated 
268 patients we studied here, telemonitoring did not compromise patients’ experience of healthcare 
269 services, and for six of our seven participants it was enhanced. Telehealth enables clinicians to 
270 remotely monitor patients, thus no travel is required, thereby providing an alternative to support 
271 those who cannot attend the clinic. It may be argued, therefore, that regular assessment through 
272 telemonitoring may reduce clinical appointments while promoting tailored care fitting the 
273 individual’s needs. The increased awareness of symptoms through telemonitoring is further aided by 
274 the messaging system, which functions as a contact point to appropriately notify clinicians of the 
275 issues and the need for further assessment. This is particularly beneficial when a patient experiences 
276 a significant change in symptoms. It was only here where full appreciation of motor challenges for 
277 this patient population is needed to ensure there are no barriers with being able to send a message. 
278 Effective interactions made through telehealth are anticipated to also contribute to efficiency 
279 savings if, this became a general approach. This fits well with the NHS Quality, Innovation, 
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280 Productivity and Prevention (QIPP) approach which is designed to improve the quality of care, while 
281 making efficiency savings to reinvest into the system [32]. 
282 The finding of positive experiences of using telemonitoring reported here is encouraging as it 
283 suggests that telemonitoring, using a device such as Careportal®, would allow an effective tailored 
284 approach while enhancing the experience of patients and their caregivers. The results advocate 
285 further investigation, ideally with a controlled trial, and separate caregiver interviews, to assess the 
286 overall impact of telehealth on care in MND patients, particularly those in the advanced stage on 
287 NIV. We are now designing a study to test the feasibility of telemonitoring for the routine care of NIV 
288 MND patients in collaboration with a local Clinical Commissioning Group (CCG) which provides 
289 telehealth to other illness groups [5]. 
290
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Table 1: Demographics and illness characteristics of patients at the time of trial
Patient
(pesudonym)
age Illness 
duration
NIV 
duration
(month)
Onset type ALSFRS-R 
Baseline
ALSFRS-R
Post-trial
Carer Living arrangement
Charlie 62 11y 10m 18 Limb 21 21 Spouse with a spouse and child(ren)
James 58 5y 7m 34 Limb 37 31 - with a partner
John 49 13y 7m 36 Limb 6 6 Professional home carer alone
Logan 66 14m 12 Respiratory 37 28 Spouse with a spouse and child(ren)
Margaret 68 8m 0 Limb 25 15 Daughter alone
Mary 68 14m 10 Limb 22 21 Spouse with a spouse
William 71 7m 4 Limb 34 33 - with a child(ren)
NIV: non-invasive ventilation, ALSFRS-R:  revised amyotrophic lateral sclerosis functional rating scale [20,21]
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Table 2: Quotes for ‘Benefits of timely intervention’
Quote
(1) a You know that was very good. Because the oximetry, when it worked, it was very good 
because [physio] could be on the work: “Well, we need to alter these settings [on NIV]”. You 
had that once, didn’t you? [Mary’s husband]
(1) b I don’t see myself as being that ill. But I can really understand needing it or using it if you are in 
the worse situation sort of thing. You could have poor breathing because of a disease – MND – 
or whatever. I could see it being really useful then. [James]
(1) c It was probably just making me feel a little bit safer because I knew when you… get all the 
answers, as soon as you’ve seen something not regular, you’d ring me up. [Logan]
(1) d Once it starts to deteriorate more it would be even more… you know, more vital to have it 
[Careportal®] then. Because if you are okay up here, your well-being is going to be better. You 
know, [if] you are thinking more; if you are worrying about everything then it’s going to be 
worse for you. [Charlie]
(1) e Because he [John] has those carers coming in like five times a day, six times a day – I don’t 
know. Six times a day? [John indicates six] It is [six]. You know morning and then the mid-
morning like now and there’s lunch call and then it’s mid-afternoon, then it’s tea call, then it’s 
mid-evening call, and then put to bed call. So, he’s always got somebody in here anyway and 
we should all notice if anything happens to him. [John’s home carer]
(1) f It [Careportal®] would be handy for 99% of people. [John]
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Table 3: Quotes for ‘Reducing the unnecessary’
Quote
(2) a I go to [hospital 1] every six months with [neurologist] and that [it] lasts for between 30 
seconds and 2 minutes. He goes, ‘How are you? Yeah, yeah. Okay. See you then.’ And the same 
[physician] I’ve probably seen – is it every 6 months? Or 12 months? I think it’s 6 months I see 
[physician] or one of his people. Same sort of thing – I walk in and ‘How are you?’ ‘Yeah, fine 
off you go.’ If it stops you doing that it would be brilliant. There is no need. [James]
(2) b It’ll save a lot of money as well as you know because I won’t need to keep going to hospital 
when I don’t need to go. [Charlie]
(2) c It’s – I’m taking their [clinicians] time up, taking car parking space up – it’s just… Careportal® is 
the way to go for me [James].
(2) d Margaret: [on iPad]: Doctor doesn’t say much. 
Daughter: [Laughs] I know I know what she is referring to. I know. You see, when we go to the 
neurology clinic … Like I say, it’s a big thing to get my mum washed, dressed, in a wheelchair to 
the hospital and you sort of go in and ‘How are you?’ ‘Alright’ ‘Okay then I will see you.’ It’s 
literally that short that appointment. There’s no - there’s no benefit to her do you know? It’s a 
big thing for my mum to go there do you know what I mean? It’s like, ‘Why?’ [Laughs] You 
know so in that respect yeah because it… there is no point in going to that appointment do you 
know what I mean because you get absolutely nothing – not a thing. 
(2) e I would like to see the doctors now and again just for peace of mind. […] They tell you exactly 
what you should be doing or what you are doing wrong and even if there’s a slight 
deterioration you know they tell you. [Logan]
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Table 4: Quotes for ‘Increased self-awareness’
Quote
(3) a Basically, I’m monitoring every day in my head anyway. I know when I’m having a good day 
and when I’m having a bad day. [Logan]
(3) b But sometimes you can feel … and you think, ‘I’ll check that’. Then you know yourself when 
you are not quite up to scratch then it [oximetry reading] will just confirm it – that’s about it. 
[Charlie]
(3) c When you get questions on about ‘Have you had phlegm?’ and ‘What colour the phlegm is?’ 
and all that - it probably makes you think about that side of it because without pressing them 
buttons, I wouldn’t even think about that. [Logan]
(3) d I think it is very easy for people to just get locked into what they are experiencing, and you can 
look at it in a more negative ways, whereas the Careportal® was asking questions and you 
think, ‘Oh… I answered similar earlier in the week’, you know, ‘Things are ok.’ It’s not, ‘Oh no, I 
feel a lot worse’, or whatever. Or, ‘I’m having more and more phlegm’ – I think it was just 
making us both aware of what was happening. And it was fairly consistent. [Mary’s husband]
(3) e Patient: I think you’ve got to be honest with your answers. 
Interviewer: So, if you were not completing the Careportal®, you might just ignore symptoms? 
Patient: There was – ‘Have you had phlegm?’ Maybe you had a little bit [but] you put ‘No’. So, 
not helping yourself. 
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Table 5: Quotes for ‘Taking initiative’
Quote
(4) a If you’ve got a problem, no matter what time it is, you can type it in. Okay, there is no-one to 
be there until the next day, but you type in what your problem is at that time and you know at 
some point someone will get back to you. [James]
(4) b We don’t really have a great deal of communication. The only thing you have is they send you 
out an appointment and you go to your appointment and you come away until next one and 
that’s pretty much all the communication that you have.  [Margaret’s daughter]
(4) c Very rare, isn’t it that you [John] need to speak to anybody, is there really? And if you do, you’ll 
send an email to somebody, won’t you? You know, he’ll… that’s how he’ll contact people - by 
an email. [John’s home carer]
Page 23 of 27
URL: http:/mc.manuscriptcentral.com/drtech  Email: IMPT97@aol.com
Disability and Rehabilitation: Assistive Technology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
23
Table 6: Quotes for ‘Technical challenges’
Quote
(5) a The keyboard is that frustrating I just couldn’t be bothered trying to get it to work because it 
wouldn’t. [William]
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Interview schedule for semi-structured interviews
Both patient and caregiver:
1. What was it like to use the Careportal? 
- Positive 
- Negative
2. Was the Careportal useful at that time it was offered to you/patient? (Ask 
participants to expand their response.)
3. Were there any problems resulted from using the Careportal? If so what were they?
4. Please tell us any bad points about using this device. (if not already covered in Q1)
5. Did you have any contacts from clinicians due to the answers you provided on the 
device? How useful was the follow up action?  
6. How did you find this way of working with you in comparison to the normal way of 
treatment you receive? 
-before Careportal
-after Careportal
7. Was there any time you wanted to get in touch with us using Careportal, but you 
didn’t? If so, what stopped you? 
8. Do you think using this device in MND service routinely would be useful and if so 
why/how? 
9. How did you feel about monitoring your own/patient’s symptoms of MND? 
(positive/negative)
10. How did you find the handling of the device? 
11. How can we improve technical aspects of Careportal? 
Additional question for caregiver (after the first question):
12. What impact did the Careportal have on you as opposed to its impact on [Patient]?   
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Appendix 2: Qualitative codes
Theme Supreme code Code Source
(no. of participants): name
Effectiveness of 
telemonitoring
Real time information 6: James, Charlie, Mary, 
Logan, William, Margaret
Physiological well-being Effective interactions 5: James, Charlie, Mary, 
William, Margaret
Enjoy using Careportal® 2: Charlie, Mary
Feeling Valued 1: Mary
Good feeling 1: William
Peace of mind/sense of security 5: Charlie, James, Mary, 
Logan, Margaret
Psychological well-being
Significance of psychological 
well-being
2: Charlie, Mary
No perceived medical benefits 3: James, Charlie, John
Benefits of 
timely 
Intervention
No perceived benefits 
Already having a good support 
system
1: John
No perceived benefits of 
outpatient appointment
5: James, Charlie, John, 
William, Margaret
Health economics 2: James, William
Hassles of hospital visits 3: Mary, William, Margaret
Savings
Less financial burdens 1: Charlie
Reducing the 
Unnecessary
Value of face-to-face 
consultation
4: James, Charlie, Mary, Logan
Self-monitoring 4: Charlie, James, Mary, 
Logan, Margaret
Increased Self-awareness
Careportal® as educational 2: Charlie, Logan
Increased Self-
awareness
Further promoting self-
care
2: Charlie, Mary
Message to get in touch 5: James, Charlie, Mary, 
Logan, Margaret
Active role in the care
Careportal® as a backup 5: James, Charlie, Mary, 
Logan, Margaret
Asking questions via messaging 
system
3: Charlie, Mary, Margaret
Contact to get accessories 2: Charlie, Logan
Taking 
initiative
Contact with hospital
Personal contact through 
Careportal®
2: Mary, Logan
Page 26 of 27
URL: http:/mc.manuscriptcentral.com/drtech  Email: IMPT97@aol.com
Disability and Rehabilitation: Assistive Technology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Traditional one-way 
communication with hospital
4: Charlie, Mary, John, 
Margaret
Easiness Easiness of Careportal® 5: James, Charlie, John, Logan, 
Margaret
Messaging system 4: James, Mary, Logan, 
William 
Entry time 3: Charlie, Mary, William
Faulty machine 2: Logan, Margaret
Oximetry related 5: James, Mary, John, William, 
Margaret
Technical 
Challenges
Technical issues
Signals 1: Charlie
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